Archive - January 2022
U.S. FDA Approves Rinvoq (upadacitinib) to Treat Adults and Children 12 Years and Older with Refractory, Moderate to Severe Atopic Dermatitis
AstraZeneca’s Vaxzevria trial provides further support for protection against COVID-19 variants
BMS and 2seventy bio move away from CAR-T programme
New study finds AstraZeneca booster generates higher antibodies against Omicron
Collaborative research approach set to accelerate treatment of Alport syndrome
Where to Buy Safe and Trusted CBD Products
4 Fun Workout Subscription Apps That Will Motivate You to Lose Weight
Why You Should Start a Keto Diet (and How to Succeed Along the Way)